Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Allergy Immunotherapy Market Size Changed, over the years?

The market of allergy immunotherapy has experienced a significant expansion in the past few years. From $2.88 billion in 2024, it’s projected to rise to $3.17 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. Factors contributing to its growth over the historical period include a surge in allergic disease cases, advances in immunotherapy methods, heightened patient awareness, government support, and enhancements in research and development.

How Much Will the Allergy Immunotherapy Market Be Worth in 2029?

The market size for allergy immunotherapy is predicted to see a swift expansion in the coming years. It is projected to grow to $5.07 billion in 2029, witnessing a compound annual growth rate (CAGR) of 12.4%. The growth anticipated in this forecast period is due to various factors like the increasing global allergy load, supportive healthcare policies, growing acceptance of immunotherapy, emergence of new markets and untapped regions, and a rise in healthcare expenditure. Notable trends in the forecast period encompass progress in treatment technology, escalating prevalence of allergies, increasing patient awareness, and education efforts, telemedicine, remote monitoring, and personalized treatment plans.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

Which is the Largest Company in the Allergy Immunotherapy Market?

Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

What Are the Main Market Drivers in the Allergy Immunotherapy Industry?

The allergy immunotherapy market is expected to witness significant growth, primarily due to the increasing incidence of allergic disorders. These disorders are characterized by exaggerated immune reactions to specific antigens. Autoimmune diseases, on the other hand, occur when the immune system mistakenly attacks the body’s own parts. Allergy immunotherapy is typically administered to atopic individuals suffering from allergy disorders such as IgE-mediated allergic rhinitis and allergic asthma induced by inhaled allergens like pollens and house dust mites (HDMs). For example, as reported by the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based executive agency, in August 202, English hospitals in 2022-23 had over 25,000 admissions related to allergies and anaphylaxis, a figure which is more than double the number seen in the past two decades. In another report published by the Food Standards Agency, a UK-based government body, in May 2024, it stated that around 6% of UK adults, equivalent to approximately 2.4 million individuals, suffer from food allergies, as revealed by the Patterns and Prevalence of Adult Food Allergy (PAFA) report. Therefore, this surge in allergic disorders is a primary driver for the expansion of the allergy immunotherapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9416&type=smp

How Is the Allergy Immunotherapy Market Segments Structured?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Asthma: Allergic Asthma, Non-Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies

5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies

What Strategic Trends Are Transforming the Allergy Immunotherapy Market?

Leading corporations in the allergy immunotherapy market are utilizing innovative technological products, such as the allergy component testing powered by artificial intelligence (AI), to maintain their market standing. The AI-powered allergy component testing is a cutting-edge testing platform that uses component resolved diagnostics (CRD) for identifying various types of allergies. For example, Metropolis Healthcare Limited, a medical laboratory company based in India, launched its AI-powered allergy component testing in May 2023. This fourth-generation allergy testing technology leverages AI to aid clinicians in making medical decisions. It offers valuable insights, which help in selection and optimization of treatment plans for allergic diseases. Additionally, it has the ability to predict the success of immunotherapy for allergy vaccinations.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Global Regions Offer the Highest Growth in the Allergy Immunotherapy Market?

Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9416

This Report Delivers Insight On:

1. How big is the allergy immunotherapy market, and how is it changing globally?

2. Who are the major companies in the allergy immunotherapy market, and how are they performing?

3. What are the key opportunities and risks in the allergy immunotherapy market right now?

4. Which products or customer segments are growing the most in the allergy immunotherapy market?

5. What factors are helping or slowing down the growth of the allergy immunotherapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model